UnitedHealth Group Inc. (NYSE:UNH) had its price objective hoisted by Oppenheimer Holdings Inc. from $161.00 to $171.00 in a report released on Wednesday morning. The brokerage currently has an outperform rating on the healthcare conglomerate’s stock.

Several other research firms also recently commented on UNH. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $170.00 to $178.00 and gave the stock an overweight rating in a research note on Wednesday. Mizuho upgraded shares of UnitedHealth Group from a neutral rating to a buy rating and set a $178.00 target price for the company in a research report on Wednesday. Leerink Swann boosted their target price on shares of UnitedHealth Group from $185.00 to $195.00 and gave the company an outperform rating in a research report on Wednesday. RBC Capital Markets boosted their target price on shares of UnitedHealth Group from $168.00 to $175.00 and gave the company an outperform rating in a research report on Wednesday. Finally, Jefferies Group boosted their target price on shares of UnitedHealth Group from $168.00 to $182.00 and gave the company a buy rating in a research report on Wednesday. Two investment analysts have rated the stock with a hold rating and twenty-three have given a buy rating to the company. The stock has an average rating of Buy and an average target price of $162.71.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (NYSE:UNH) opened at 158.32 on Wednesday. The company has a market cap of $150.69 billion, a P/E ratio of 23.39 and a beta of 0.63. The firm’s 50 day moving average is $143.81 and its 200 day moving average is $139.88. UnitedHealth Group has a 12-month low of $107.51 and a 12-month high of $154.50.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The business earned $46.30 billion during the quarter, compared to the consensus estimate of $46.09 billion. During the same period in the previous year, the firm posted $1.77 earnings per share. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group will post $8.01 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Inc. (UNH) Price Target Raised to $171.00 at Oppenheimer Holdings Inc.” was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another website, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be read at http://www.dailypolitical.com/2016/12/01/unitedhealth-group-inc-unh-price-target-raised-to-171-00-at-oppenheimer-holdings-inc.html.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Stockholders of record on Friday, December 2nd will be issued a $0.625 dividend. The ex-dividend date of this dividend is Wednesday, November 30th. This represents a $2.50 annualized dividend and a dividend yield of 1.58%. UnitedHealth Group’s dividend payout ratio is currently 36.93%.

In other UnitedHealth Group news, EVP D Ellen Wilson sold 14,365 shares of the stock in a transaction that occurred on Friday, October 21st. The shares were sold at an average price of $144.18, for a total transaction of $2,071,145.70. Following the sale, the executive vice president now directly owns 66,635 shares in the company, valued at approximately $9,607,434.30. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Gail R. Wilensky sold 5,460 shares of the stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $150.55, for a total transaction of $822,003.00. Following the sale, the director now owns 60,052 shares in the company, valued at $9,040,828.60. The disclosure for this sale can be found here. Company insiders own 1.65% of the company’s stock.

Large investors have recently added to or reduced their stakes in the company. Van Hulzen Asset Management LLC acquired a new stake in UnitedHealth Group during the second quarter worth about $104,000. Coconut Grove Bank raised its stake in UnitedHealth Group by 19.5% in the third quarter. Coconut Grove Bank now owns 736 shares of the healthcare conglomerate’s stock worth $103,000 after buying an additional 120 shares during the period. First Personal Financial Services raised its stake in UnitedHealth Group by 36.9% in the third quarter. First Personal Financial Services now owns 742 shares of the healthcare conglomerate’s stock worth $104,000 after buying an additional 200 shares during the period. Itau Unibanco Holding S.A. acquired a new stake in UnitedHealth Group during the third quarter worth about $111,000. Finally, Archford Capital Strategies LLC raised its stake in UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 696 shares during the period. Institutional investors own 84.92% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.